[ LifeArc - Call for the development and testing of therapeutics to treat COVID-19 | Research funding ]
Event details
| Date | 06.04.2020 |
| Category | Call for proposal |
LifeArc is a UK registered and self-funding charity, which focuses on improving the lives of patients by supporting medical research and by developing and bringing diagnostics and medicines to the market with its translational research laboratories in Stevenage and Edinburgh.
LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run clinical trials in patients during the current epidemic. It is anticipated that applications will be for funding to repurpose one or more drugs that are generic, already licensed, or are in late stage development for another indication. Plans for the structure of the clinical trials should be in advanced stages of development and should follow the specialist guidance from the regulators on COVID-19 trials.
Who can apply: LifeArc is calling for applications from academics, NHS employees or companies from any geographical location that have therapeutics that could be repurposed or repositioned for use in COVID-19 patients.
Duration: Priority will be given to projects that have a clear path and availability for patients in a 6-12 month timeframe.
Funding: now upper or lower limit.
Eligible costs: direct costs of the trials and the science associated with that.
Deadline: 6 April 2020.
Decision: 27 April 2020.
Start of the project: as soon as possible.
For further information, please have a look at the call webpage.
LifeArc has made available an initial £10M for the identification of therapeutics that can be rapidly deployed to treat COVID-19. The aim is to run clinical trials in patients during the current epidemic. It is anticipated that applications will be for funding to repurpose one or more drugs that are generic, already licensed, or are in late stage development for another indication. Plans for the structure of the clinical trials should be in advanced stages of development and should follow the specialist guidance from the regulators on COVID-19 trials.
Who can apply: LifeArc is calling for applications from academics, NHS employees or companies from any geographical location that have therapeutics that could be repurposed or repositioned for use in COVID-19 patients.
Duration: Priority will be given to projects that have a clear path and availability for patients in a 6-12 month timeframe.
Funding: now upper or lower limit.
Eligible costs: direct costs of the trials and the science associated with that.
Deadline: 6 April 2020.
Decision: 27 April 2020.
Start of the project: as soon as possible.
For further information, please have a look at the call webpage.
Practical information
- General public
- Free